Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • James Dunn

  • Staff Writer

  • The Inside Adviser

Getting to know Angela Ashton

This week we spoke with Angela Ashton, founder of Evergreen Consulting, who recently launched her Investment Research business. Angela, can you tell us a little about yourself; what has been your favourite weekend activity in COVID-19 lockdown? Watching Netflix, walking, and drinking rosé. And your favourite holiday destination pre-COVID 19?Too many – I love New…
The Inside Adviser | 22nd Oct 2020 | More
Evergreen Ratings – a new player in research

A busy year for investment researchers just got busier, with Evergreen Consulting launching its own investment research arm, Evergreen Ratings. This follows a number of acquisitions and asset sales in the sector. The group will run alongside the existing Evergreen Consulting business, which was founded by the irrepressible Angela Ashton. Evergreen Consulting has quickly built…
The Inside Adviser | 12th Oct 2020 | More
Device Stars Part 3

4DMedical (4DX, $1.58)Market capitalisation: $418 millionThree-year total return: n/aAnalysts’ consensus target price: $1.70 (Thomson Reuters) Imaging company 4DMedical (4DX) surged on to the ASX screens in its August float, at a 100% “pop.” Issued in the prospectus at 73 cents, the shares opened for trade on August 7 at $1.47, and reached $1.70 in August…
James Dunn | 21st Sep 2020 | More
    • Getting back to normal with Franklin Templeton

    Franklin Equity Group’s John Remmert and Donald Huber share which trends they think are permanent and which are likely just a phase.
    Staff Writer | 25th May 2020 | More